XD9D:XETRA:XETRA-Xtrackers MSCI USA UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 21.292

Change

+0.85 (+4.16)%

Market Cap

USD 0.02B

Volume

3.02K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.89 (+1.76%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.28 (+1.72%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.42 (+1.57%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.45 (+1.61%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.42 (+1.73%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.87 (+1.94%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+2.20 (+1.54%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.84 (+1.68%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+3.07 (+3.13%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+23.06 (+4.12%)

USD 80.38B

ETFs Containing XD9D:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.41% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.41% 89% A- 87% B+
Trailing 12 Months  
Capital Gain 34.68% 86% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.68% 86% B+ 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.74% 64% D 63% D
Dividend Return 8.74% 63% D 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.06% 52% F 61% D-
Risk Adjusted Return 72.50% 69% C- 73% C
Market Capitalization 0.02B 13% F 12% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.